Mimetogen Pharmaceuticals

Mimetogen Pharmaceuticals, a biotechnology company, develops novel small molecule compounds to treat neurodegenerative diseases of the eye.

Mimetogen Pharmaceuticals is a venture-backed biotechnology company founded by Prof. H. Uri Saragovi and Dr. Garth Cumberlidge. The company is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinitis pigmentosa. All these diseases represent very large unmet medical needs, particularly for the aging population.